Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study

R.H.G.J. van Lanen; C. J. Wiggins; A.J. Colon; W. H. Backes; J.F.A. Jansen; D. Uher; G.S. Drenthen; A. Roebroeck; D. Ivanov; B.A. Poser; M.C. Hoeberigs; S.M.J. van Kuijk; G. Hoogland; K. Rijkers; G.L. Wagner; J. Beckervordersandforth; D. Delev; H. Clusmann; S. Wolking; S. Klinkenberg; R.P.W. Rouhl; P.A.M. Hofman; O.E.M.G. Schijns

doi:10.1007/s00234-021-02884-8

Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study

R.H.G.J. van Lanen (Corresponding author), C. J. Wiggins, A.J. Colon, W. H. Backes, J.F.A. Jansen, D. Uher, G.S. Drenthen, A. Roebroeck, D. Ivanov, B.A. Poser, M.C. Hoeberigs, S.M.J. van Kuijk, G. Hoogland, K. Rijkers, G.L. Wagner, J. Beckervordersandforth, D. Delev, H. Clusmann, S. Wolking, S. KlinkenbergR.P.W. Rouhl, P.A.M. Hofman, O.E.M.G. Schijns

Signal Processing Systems

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Abstract

Purpose: Resective epilepsy surgery is a well-established, evidence-based treatment option in patients with drug-resistant focal epilepsy. A major predictive factor of good surgical outcome is visualization and delineation of a potential epileptogenic lesion by MRI. However, frequently, these lesions are subtle and may escape detection by conventional MRI (≤ 3 T). Methods: We present the EpiUltraStudy protocol to address the hypothesis that application of ultra-high field (UHF) MRI increases the rate of detection of structural lesions and functional brain aberrances in patients with drug-resistant focal epilepsy who are candidates for resective epilepsy surgery. Additionally, therapeutic gain will be addressed, testing whether increased lesion detection and tailored resections result in higher rates of seizure freedom 1 year after epilepsy surgery. Sixty patients enroll the study according to the following inclusion criteria: aged ≥ 12 years, diagnosed with drug-resistant focal epilepsy with a suspected epileptogenic focus, negative conventional 3 T MRI during pre-surgical work-up. Results: All patients will be evaluated by 7 T MRI; ten patients will undergo an additional 9.4 T MRI exam. Images will be evaluated independently by two neuroradiologists and a neurologist or neurosurgeon. Clinical and UHF MRI will be discussed in the multidisciplinary epilepsy surgery conference. Demographic and epilepsy characteristics, along with postoperative seizure outcome and histopathological evaluation, will be recorded. Conclusion: This protocol was reviewed and approved by the local Institutional Review Board and complies with the Declaration of Helsinki and principles of Good Clinical Practice. Results will be submitted to international peer-reviewed journals and presented at international conferences. Trial registration number: www.trialregister.nl: NTR7536.

Original language	English
Pages (from-to)	753-764
Number of pages	12
Journal	Neuroradiology
Volume	64
Issue number	4
DOIs	https://doi.org/10.1007/s00234-021-02884-8
Publication status	Published - Apr 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

Keywords

7 T
9.4 T
Epilepsy
Epilepsy surgery
UHF MRI

Access to Document

10.1007/s00234-021-02884-8

pdfFinal published version, 924 KB

Cite this

van Lanen, R. H. G. J., Wiggins, C. J., Colon, A. J., Backes, W. H., Jansen, J. F. A., Uher, D., Drenthen, G. S., Roebroeck, A., Ivanov, D., Poser, B. A., Hoeberigs, M. C., van Kuijk, S. M. J., Hoogland, G., Rijkers, K., Wagner, G. L., Beckervordersandforth, J., Delev, D., Clusmann, H., Wolking, S., ... Schijns, O. E. M. G. (2022). Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study. Neuroradiology, 64(4), 753-764. https://doi.org/10.1007/s00234-021-02884-8

@article{6b3aa083d8cf4dc3b98ce55d0edd19ff,

title = "Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study",

abstract = "Purpose: Resective epilepsy surgery is a well-established, evidence-based treatment option in patients with drug-resistant focal epilepsy. A major predictive factor of good surgical outcome is visualization and delineation of a potential epileptogenic lesion by MRI. However, frequently, these lesions are subtle and may escape detection by conventional MRI (≤ 3 T). Methods: We present the EpiUltraStudy protocol to address the hypothesis that application of ultra-high field (UHF) MRI increases the rate of detection of structural lesions and functional brain aberrances in patients with drug-resistant focal epilepsy who are candidates for resective epilepsy surgery. Additionally, therapeutic gain will be addressed, testing whether increased lesion detection and tailored resections result in higher rates of seizure freedom 1 year after epilepsy surgery. Sixty patients enroll the study according to the following inclusion criteria: aged ≥ 12 years, diagnosed with drug-resistant focal epilepsy with a suspected epileptogenic focus, negative conventional 3 T MRI during pre-surgical work-up. Results: All patients will be evaluated by 7 T MRI; ten patients will undergo an additional 9.4 T MRI exam. Images will be evaluated independently by two neuroradiologists and a neurologist or neurosurgeon. Clinical and UHF MRI will be discussed in the multidisciplinary epilepsy surgery conference. Demographic and epilepsy characteristics, along with postoperative seizure outcome and histopathological evaluation, will be recorded. Conclusion: This protocol was reviewed and approved by the local Institutional Review Board and complies with the Declaration of Helsinki and principles of Good Clinical Practice. Results will be submitted to international peer-reviewed journals and presented at international conferences. Trial registration number: www.trialregister.nl: NTR7536.",

keywords = "7 T, 9.4 T, Epilepsy, Epilepsy surgery, UHF MRI",

author = "{van Lanen}, R.H.G.J. and Wiggins, {C. J.} and A.J. Colon and Backes, {W. H.} and J.F.A. Jansen and D. Uher and G.S. Drenthen and A. Roebroeck and D. Ivanov and B.A. Poser and M.C. Hoeberigs and {van Kuijk}, S.M.J. and G. Hoogland and K. Rijkers and G.L. Wagner and J. Beckervordersandforth and D. Delev and H. Clusmann and S. Wolking and S. Klinkenberg and R.P.W. Rouhl and P.A.M. Hofman and O.E.M.G. Schijns",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = apr,

doi = "10.1007/s00234-021-02884-8",

language = "English",

volume = "64",

pages = "753--764",

journal = "Neuroradiology",

issn = "0028-3940",

publisher = "Springer Verlag",

number = "4",

}

van Lanen, RHGJ, Wiggins, CJ, Colon, AJ, Backes, WH, Jansen, JFA, Uher, D, Drenthen, GS, Roebroeck, A, Ivanov, D, Poser, BA, Hoeberigs, MC, van Kuijk, SMJ, Hoogland, G, Rijkers, K, Wagner, GL, Beckervordersandforth, J, Delev, D, Clusmann, H, Wolking, S, Klinkenberg, S, Rouhl, RPW, Hofman, PAM & Schijns, OEMG 2022, 'Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study', Neuroradiology, vol. 64, no. 4, pp. 753-764. https://doi.org/10.1007/s00234-021-02884-8

Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy): protocol for a prospective, longitudinal therapeutic study. / van Lanen, R.H.G.J. (Corresponding author); Wiggins, C. J.; Colon, A.J. et al.
In: Neuroradiology, Vol. 64, No. 4, 04.2022, p. 753-764.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Value of ultra-high field MRI in patients with suspected focal epilepsy and negative 3 T MRI (EpiUltraStudy)

T2 - protocol for a prospective, longitudinal therapeutic study

AU - van Lanen, R.H.G.J.

AU - Wiggins, C. J.

AU - Colon, A.J.

AU - Backes, W. H.

AU - Jansen, J.F.A.

AU - Uher, D.

AU - Drenthen, G.S.

AU - Roebroeck, A.

AU - Ivanov, D.

AU - Poser, B.A.

AU - Hoeberigs, M.C.

AU - van Kuijk, S.M.J.

AU - Hoogland, G.

AU - Rijkers, K.

AU - Wagner, G.L.

AU - Beckervordersandforth, J.

AU - Delev, D.

AU - Clusmann, H.

AU - Wolking, S.

AU - Klinkenberg, S.

AU - Rouhl, R.P.W.

AU - Hofman, P.A.M.

AU - Schijns, O.E.M.G.

PY - 2022/4

Y1 - 2022/4

N2 - Purpose: Resective epilepsy surgery is a well-established, evidence-based treatment option in patients with drug-resistant focal epilepsy. A major predictive factor of good surgical outcome is visualization and delineation of a potential epileptogenic lesion by MRI. However, frequently, these lesions are subtle and may escape detection by conventional MRI (≤ 3 T). Methods: We present the EpiUltraStudy protocol to address the hypothesis that application of ultra-high field (UHF) MRI increases the rate of detection of structural lesions and functional brain aberrances in patients with drug-resistant focal epilepsy who are candidates for resective epilepsy surgery. Additionally, therapeutic gain will be addressed, testing whether increased lesion detection and tailored resections result in higher rates of seizure freedom 1 year after epilepsy surgery. Sixty patients enroll the study according to the following inclusion criteria: aged ≥ 12 years, diagnosed with drug-resistant focal epilepsy with a suspected epileptogenic focus, negative conventional 3 T MRI during pre-surgical work-up. Results: All patients will be evaluated by 7 T MRI; ten patients will undergo an additional 9.4 T MRI exam. Images will be evaluated independently by two neuroradiologists and a neurologist or neurosurgeon. Clinical and UHF MRI will be discussed in the multidisciplinary epilepsy surgery conference. Demographic and epilepsy characteristics, along with postoperative seizure outcome and histopathological evaluation, will be recorded. Conclusion: This protocol was reviewed and approved by the local Institutional Review Board and complies with the Declaration of Helsinki and principles of Good Clinical Practice. Results will be submitted to international peer-reviewed journals and presented at international conferences. Trial registration number: www.trialregister.nl: NTR7536.

AB - Purpose: Resective epilepsy surgery is a well-established, evidence-based treatment option in patients with drug-resistant focal epilepsy. A major predictive factor of good surgical outcome is visualization and delineation of a potential epileptogenic lesion by MRI. However, frequently, these lesions are subtle and may escape detection by conventional MRI (≤ 3 T). Methods: We present the EpiUltraStudy protocol to address the hypothesis that application of ultra-high field (UHF) MRI increases the rate of detection of structural lesions and functional brain aberrances in patients with drug-resistant focal epilepsy who are candidates for resective epilepsy surgery. Additionally, therapeutic gain will be addressed, testing whether increased lesion detection and tailored resections result in higher rates of seizure freedom 1 year after epilepsy surgery. Sixty patients enroll the study according to the following inclusion criteria: aged ≥ 12 years, diagnosed with drug-resistant focal epilepsy with a suspected epileptogenic focus, negative conventional 3 T MRI during pre-surgical work-up. Results: All patients will be evaluated by 7 T MRI; ten patients will undergo an additional 9.4 T MRI exam. Images will be evaluated independently by two neuroradiologists and a neurologist or neurosurgeon. Clinical and UHF MRI will be discussed in the multidisciplinary epilepsy surgery conference. Demographic and epilepsy characteristics, along with postoperative seizure outcome and histopathological evaluation, will be recorded. Conclusion: This protocol was reviewed and approved by the local Institutional Review Board and complies with the Declaration of Helsinki and principles of Good Clinical Practice. Results will be submitted to international peer-reviewed journals and presented at international conferences. Trial registration number: www.trialregister.nl: NTR7536.

KW - 7 T

KW - 9.4 T

KW - Epilepsy

KW - Epilepsy surgery

KW - UHF MRI

UR - http://www.scopus.com/inward/record.url?scp=85122328529&partnerID=8YFLogxK

U2 - 10.1007/s00234-021-02884-8

DO - 10.1007/s00234-021-02884-8

M3 - Article

C2 - 34984522

AN - SCOPUS:85122328529

SN - 0028-3940

VL - 64

SP - 753

EP - 764

JO - Neuroradiology

JF - Neuroradiology

IS - 4

ER -